EIX vs SNDX · P/E 7.3, rev $19.32B vs rev $137.7M
Edison International (EIX) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the EIX and SNDX stock pages for the full models.
Not investment advice.